TELA Bio wins FDA 510(k) clearance for Liora monofilament scaffold
TELA•The FDA granted 510(k) clearance for TELA Bio’s Liora monofilament scaffold, a fully resorbable surgical mesh for soft-tissue reinforcement, expanding its addressable soft-tissue reconstruction market.
1. FDA clearance
The FDA granted 510(k) clearance for TELA Bio’s Liora monofilament scaffold, a fully resorbable surgical mesh for soft-tissue reinforcement. The clearance expands the company’s addressable soft-tissue reconstruction market.
